[go: up one dir, main page]

PE20120574A1 - Polimorfos de s,s-dioxido del acido 7-[(3-cloro-6,11-dihidro-6-metildibenzo[c,f] [1,2]tiazepin-11-il)amino]heptanoico y metodos para su preparacion - Google Patents

Polimorfos de s,s-dioxido del acido 7-[(3-cloro-6,11-dihidro-6-metildibenzo[c,f] [1,2]tiazepin-11-il)amino]heptanoico y metodos para su preparacion

Info

Publication number
PE20120574A1
PE20120574A1 PE2012000103A PE2012000103A PE20120574A1 PE 20120574 A1 PE20120574 A1 PE 20120574A1 PE 2012000103 A PE2012000103 A PE 2012000103A PE 2012000103 A PE2012000103 A PE 2012000103A PE 20120574 A1 PE20120574 A1 PE 20120574A1
Authority
PE
Peru
Prior art keywords
methyldibenzo
thiazepin
dihydro
chloro
dioxide
Prior art date
Application number
PE2012000103A
Other languages
English (en)
Inventor
Matthew Sansone
Original Assignee
Transform Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39738742&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20120574(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Transform Pharmaceuticals Inc filed Critical Transform Pharmaceuticals Inc
Publication of PE20120574A1 publication Critical patent/PE20120574A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

REFERIDA A LA FORMA II DE S,S-DIOXIDO DEL ACIDO 7-[(3-CLORO-6,11-DIHIDRO-6-METILDIBENZO[c,f][1,2]TIAZEPIN-11-IL)AMINO]HEPTANOICO (TIANEPTINA) QUE EXHIBE UN DIFRACTOGRAMA DE RAYOS X EN POLVO QUE COMPRENDE PICOS A 8,52, 10,46, 15,05, 17,14, 18,22, 20,99, 21,66, 22,68, 23,35, 23,88, 24,55 Y 26,71 (2-THETA GRADOS) Y UN TERMOGRAMA DSC QUE COMPRENDE UNA TRANSICION ENDOTERMICA A 148 ºC. TAMBIEN ESTA REFERIDA A UN PROCESO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA
PE2012000103A 2007-03-05 2008-03-05 Polimorfos de s,s-dioxido del acido 7-[(3-cloro-6,11-dihidro-6-metildibenzo[c,f] [1,2]tiazepin-11-il)amino]heptanoico y metodos para su preparacion PE20120574A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89294707P 2007-03-05 2007-03-05

Publications (1)

Publication Number Publication Date
PE20120574A1 true PE20120574A1 (es) 2012-05-23

Family

ID=39738742

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2012000103A PE20120574A1 (es) 2007-03-05 2008-03-05 Polimorfos de s,s-dioxido del acido 7-[(3-cloro-6,11-dihidro-6-metildibenzo[c,f] [1,2]tiazepin-11-il)amino]heptanoico y metodos para su preparacion
PE2008000432A PE20090534A1 (es) 2007-03-05 2008-03-05 Polimorfos de s,s-dioxido del acido 7-[(3-cloro-6,11-dihidro-6-metildibenzo[c,f] [1,2]tiazepin-11-il)amino]heptanoico y metodos para su preparacion y uso

Family Applications After (1)

Application Number Title Priority Date Filing Date
PE2008000432A PE20090534A1 (es) 2007-03-05 2008-03-05 Polimorfos de s,s-dioxido del acido 7-[(3-cloro-6,11-dihidro-6-metildibenzo[c,f] [1,2]tiazepin-11-il)amino]heptanoico y metodos para su preparacion y uso

Country Status (11)

Country Link
US (1) US8367656B2 (es)
EP (1) EP2137157A4 (es)
JP (1) JP2010520298A (es)
AR (1) AR065602A1 (es)
CA (1) CA2679936C (es)
CL (1) CL2008000653A1 (es)
JO (1) JO3046B1 (es)
PE (2) PE20120574A1 (es)
TW (1) TWI436988B (es)
UY (1) UY30952A1 (es)
WO (1) WO2008109577A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8198268B2 (en) * 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
US10624902B1 (en) 2017-08-08 2020-04-21 James Peter Morrissette Dietary supplement
WO2019064071A1 (en) * 2017-09-27 2019-04-04 F. Hoffmann-La Roche Ag CRYSTALLINE FORMS OF DIAZABICYCLOOCTANE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3758528A (en) 1970-03-13 1973-09-11 Science Union & Cie Tricyclic compounds
JPS535661B2 (es) * 1972-03-07 1978-03-01
CA995213A (fr) 1972-03-16 1976-08-17 Charles Malen Procede de preparation de derives tricycliques
FR2594827B1 (fr) * 1986-02-21 1988-05-20 Adir Nouveau derive tricyclique denomme acide ((chloro-3 methyl-6 dioxo-5,5 dihydro-6, 11 dibenzo (c,f) thiazepine (1,2) yl-11 amino)-5 pentazoique, son procede de preparation et les compositions pharmaceutiques qui le contiennent
FR2716623B1 (fr) * 1994-02-25 1996-08-23 Adir Utilisation d'un dérivé tricyclique pour l'obtention de médicaments destinés au traitement des troubles mnémo-cognitifs.
GB9624615D0 (en) * 1996-11-26 1997-01-15 Zeneca Ltd Chrystallisation process
WO2000046224A2 (en) * 1999-02-04 2000-08-10 American Home Products Corporation Tricyclic pyridine n-oxides vasopressin agonists
ES2261730T3 (es) * 2001-05-05 2006-11-16 Accentus Plc Formacion de cristales pequeños.
US6683072B1 (en) * 2003-02-04 2004-01-27 Vela Pharmaceuticals, Inc. Compositions and methods for treatment of irritable bowel syndrome and nonulcer dyspepsia

Also Published As

Publication number Publication date
CA2679936A1 (en) 2008-09-12
UY30952A1 (es) 2008-09-30
AR065602A1 (es) 2009-06-17
EP2137157A4 (en) 2010-12-15
EP2137157A1 (en) 2009-12-30
JP2010520298A (ja) 2010-06-10
TWI436988B (zh) 2014-05-11
TW200846331A (en) 2008-12-01
CL2008000653A1 (es) 2008-10-24
US20080221081A1 (en) 2008-09-11
CA2679936C (en) 2017-07-11
PE20090534A1 (es) 2009-05-03
US8367656B2 (en) 2013-02-05
WO2008109577A1 (en) 2008-09-12
JO3046B1 (ar) 2016-09-05

Similar Documents

Publication Publication Date Title
CO6480979A2 (es) Inhibidores de bace
CL2008000496A1 (es) Compuestos derivados de purina; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar enfermedades infecciosas, cancer, alergias y otras afecciones inflamatorias.
AR068369A1 (es) Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina"
BRPI1012993A2 (pt) "uso de um anticorpo anti-tau ps422 para o tratamento de doenças do cérebro"
CL2011002943A1 (es) Anticuerpo triespecifico o tetraespecifico; metodo para la preparacion de dicho anticuerpo; celula huesped; composicion farmaceutica.
BRPI0816553A2 (pt) "composto, composição farmcêutica, uso de uma composição, uso de um composto, e, processo para a preparação de um composto"
GT201100205A (es) Dicianopiridinas alquilamino-sustituidas y sus profármacos de éster de aminoácido
BRPI0923728A2 (pt) "método de preparação de compostos de di-hidroindeno amida, suas composições farmacêuticas contendo esses compostos e uso como inibidor de proteína quinase".
ECSP12012318A (es) Inhibidores de pirazolil quinazolina cinasa
PT2504005E (pt) Utilização de derivados de 1,3-difenilprop-2-en-1-ona para tratamento de doenças hepáticas
CL2011001830A1 (es) Forma cristalina del hidrocloruro de n-[(1s)-2-amino-1-[(3-fluorofenil)metil]etil]-5-cloro-4-(4-cloro-1-metil-1h-pirazol-5-il)-2-tiofenocarboxamida; composicion farmaceutica; combinacion farmaceutica; proceso para preparar la composicion farmaceutica; y su uso para tratar o disminuir una enfermedad seleccionada de cancer y artritis.
BRPI0818533A2 (pt) composto, composição farmacêutica, e, processo para a preparação de um composto
ECSP11011151A (es) Compuestos purina
BRPI0815613A2 (pt) Composições lipossômicas para administração in vivo de compostos de ácido borônico.
BRPI0906475A2 (pt) Compostos, processso para a preparação de um composto, composição farmacêutica e uso de um composto
CL2008003472A1 (es) Compuestos derivados de 5-[3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino]-1h-quinolin-2-ona, proceso para la preparacion de los mismos, compuestos intermediarios, composicion farmaceutica que comprende dicho compuesto; combinacion farmaceutica, y sus usos en el tratamiento de enfermedades inflamatorias.
BR112012004173A2 (pt) "composto, composição, método para preparar uma composição, e, uso de um composto"
BRPI0914410A2 (pt) composição de polidesoxirribonucleotídeo injetável para o tratamento de doenças osteoarticulares.
CL2011001405A1 (es) Procedimiento para la preparacion de n-[2-(7-metoxi-1-naftil)etil]acetamida, agometalina.
BR112012016201A2 (pt) ''composto, processo para a preparação de um composto, composição farmacêutica e uso de um composto''
NZ600263A (en) 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof
BRPI0912890A2 (pt) composição farmacêutica para o tratamento de ejaculação precoce
CL2008000554A1 (es) Compuestos derivados de diaminopirimidina sustituida; metodo de preparacion de dichos compuestos; composicion farmaceutica; y uso del compuesto para el tratamiento de una enfermedad del tracto urinario, un estado patologico doloroso, un trastorno res
PE20120574A1 (es) Polimorfos de s,s-dioxido del acido 7-[(3-cloro-6,11-dihidro-6-metildibenzo[c,f] [1,2]tiazepin-11-il)amino]heptanoico y metodos para su preparacion
WO2010079045A3 (en) Crystalline salt forms of flibanserine

Legal Events

Date Code Title Description
FC Refusal